Free Trial

Growth Stocks To Consider - May 13th

Novo Nordisk A/S logo with Medical background

Novo Nordisk A/S, Blackstone, and BlackRock are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose revenues and earnings are projected to grow at a significantly faster pace than the overall market. These firms typically reinvest profits into expansion, research and development, or new projects rather than paying out dividends. As a result, growth stocks often carry higher price‐to‐earnings ratios and greater volatility, reflecting investors’ expectations for continued rapid growth. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Novo Nordisk A/S stock traded down $2.25 during trading on Tuesday, reaching $65.49. The company had a trading volume of 6,891,686 shares, compared to its average volume of 6,433,420. The company has a current ratio of 0.74, a quick ratio of 0.55 and a debt-to-equity ratio of 0.62. The firm's 50-day simple moving average is $68.75 and its 200 day simple moving average is $85.51. The firm has a market capitalization of $293.89 billion, a price-to-earnings ratio of 19.91, a price-to-earnings-growth ratio of 0.90 and a beta of 0.65. Novo Nordisk A/S has a 52 week low of $57.00 and a 52 week high of $148.15.

Read Our Latest Research Report on NVO

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Shares of BX traded up $1.16 during mid-day trading on Tuesday, reaching $150.16. 1,712,442 shares of the company's stock traded hands, compared to its average volume of 3,768,871. The stock has a market cap of $109.56 billion, a P/E ratio of 41.37, a P/E/G ratio of 1.07 and a beta of 1.67. The stock's 50-day moving average is $136.80 and its two-hundred day moving average is $162.05. Blackstone has a 12 month low of $115.66 and a 12 month high of $200.96. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.67 and a quick ratio of 0.71.

Read Our Latest Research Report on BX

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

Shares of NYSE BLK traded up $5.77 during trading hours on Tuesday, reaching $963.80. The stock had a trading volume of 231,036 shares, compared to its average volume of 684,903. The company has a current ratio of 5.23, a quick ratio of 5.23 and a debt-to-equity ratio of 0.45. The firm has a market cap of $149.63 billion, a price-to-earnings ratio of 22.95, a P/E/G ratio of 1.90 and a beta of 1.41. The business's fifty day moving average price is $912.82 and its two-hundred day moving average price is $978.29. BlackRock has a 52-week low of $752.30 and a 52-week high of $1,084.22.

Read Our Latest Research Report on BLK

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novo Nordisk A/S Right Now?

Before you consider Novo Nordisk A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novo Nordisk A/S wasn't on the list.

While Novo Nordisk A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines